These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28169975)

  • 1. Simple Urine Test to Evaluate Adherence to Oral 5-ASA in Teenagers With Ulcerative Colitis: Proof of Concept.
    Dijkstra A; Touw DJ; van Rheenen PF
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):416-419. PubMed ID: 28169975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study.
    Gifford AE; Berg AH; Lahiff C; Cheifetz AS; Horowitz G; Moss AC
    Am J Gastroenterol; 2013 Feb; 108(2):249-55. PubMed ID: 23295279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
    Yen L; Wu J; Hodgkins PL; Cohen RD; Nichol MB
    J Manag Care Pharm; 2012; 18(9):701-12. PubMed ID: 23206213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.
    Römkens TEH; Te Morsche R; Peters W; Burger DM; Hoentjen F; Drenth JPH
    Br J Clin Pharmacol; 2018 Mar; 84(3):477-481. PubMed ID: 29073323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.
    Lee J; Jee SR; Kim HW; Baek DH; Song GA; Moon W; Park SJ; Kim HJ; Lee JH; Park JH; Kim TO;
    PLoS One; 2019; 14(3):e0214129. PubMed ID: 30901362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adherence to oral 5-aminosalicylic acid by patients with quiescent ulcerative colitis: a questionnaire survey].
    Kato S; Kani K; Kobayashi T; Yamamoto R; Nagoshi S; Yakabi K
    Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1819-29. PubMed ID: 26440684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis.
    Olmstead J
    J Am Acad Nurse Pract; 2010 Nov; 22(11):586-92. PubMed ID: 21054632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial.
    Moshkovska T; Stone MA; Smith RM; Bankart J; Baker R; Mayberry JF
    Inflamm Bowel Dis; 2011 Sep; 17(9):1874-81. PubMed ID: 21830265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.
    Boyle M; Ting A; Cury DB; Nanda K; Cheifetz AS; Moss A
    Inflamm Bowel Dis; 2015 Dec; 21(12):2873-8. PubMed ID: 26313693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements.
    Moshkovska T; Stone MA; Clatworthy J; Smith RM; Bankart J; Baker R; Wang J; Horne R; Mayberry JF
    Aliment Pharmacol Ther; 2009 Dec; 30(11-12):1118-27. PubMed ID: 19785623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study.
    Yokoyama H; Takagi S; Kuriyama S; Takahashi S; Takahashi H; Iwabuchi M; Takahashi S; Kinouchi Y; Hiwatashi N; Tsuji I; Shimosegawa T
    Inflamm Bowel Dis; 2007 Sep; 13(9):1115-20. PubMed ID: 17455207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis.
    Cuffari C; Pierce D; Korczowski B; Fyderek K; Van Heusen H; Hossack S; Wan H; Edwards AY; Martin P
    Drug Des Devel Ther; 2016; 10():593-607. PubMed ID: 26893546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system.
    Khan N; Abbas AM; Bazzano LA; Koleva YN; Krousel-Wood M
    Aliment Pharmacol Ther; 2012 Oct; 36(8):755-64. PubMed ID: 22882428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Adherence in Patients with Ulcerative Colitis Is Dependent on the Formulation of 5-Aminosalicylic Acid.
    Nakagawa S; Okaniwa N; Mizuno M; Sugiyama T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Funaki Y; Sasaki M; Kasugai K
    Digestion; 2019; 99(2):133-139. PubMed ID: 30179881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence.
    Nikolaus S; Schreiber S; Siegmund B; Bokemeyer B; Bästlein E; Bachmann O; Görlich D; Hofmann U; Schwab M; Kruis W
    J Crohns Colitis; 2017 Sep; 11(9):1052-1062. PubMed ID: 28486634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A curious case of red-brown urine in a child taking mesalamine.
    Sacks A; Davis MK
    J Pediatr Gastroenterol Nutr; 2013 May; 56(5):e38-9. PubMed ID: 23403443
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
    Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM
    Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
    Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
    Patient; 2012; 5(1):33-44. PubMed ID: 22077619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.